Tokyo, Sept. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062831) titled 'A Study of a Model for Predicting Hepatocellular Carcinoma After SVR in Patients with Non-Cirrhotic Hepatitis C in East Asia' on Sept. 6.
Study Type:
Observational
Primary Sponsor:
Institute - The University of Osaka
Condition:
Condition - Chronic hepatitis C
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the utility of a liver cancer prediction model in patients with hepatitis C without cirrhosis who achieved viral eradication through interferon-free therapy
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with hepatitis C without cirrhosis who achieved SVR with interferon-free DAA therapy
Key exclusion criteria - Cases of cirrhosis (defined as cases in which cirrhosis was clinically diagnosed based on blood tests, fibrosis markers, liver stiffness measurements, etc.)
Cases in which hepatocellular carcinoma developed prior to achieving SVR
Cases with concomitant liver disease
Target Size - 5000
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2026 Year 04 Month 04 Day
Date of IRB - 2026 Year 06 Month 19 Day
Anticipated trial start date - 2026 Year 06 Month 23 Day
Last follow-up date - 2031 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069988
Disclaimer: Curated by HT Syndication.
